Many Continuing Care Retirement Communities (CCRCs), also known as Life Plan Communities (LPCs), are facing complex and dynamic challenges. In addition to the significant pressure of supporting an aging baby […]
Read More
Entity-owned pharmacies are an important consideration for hospitals, community health centers, and other 340B grantee types. As retail pharmacy closures rise and the complexities of the 340B Drug Discount Program […]
Read More
To appeal or not to appeal: that is the question. Medicare cost report appeals can be extremely profitable, but which issues are worth the time and effort to appeal? Without […]
Read More
The therapy team plays a pivotal role in ensuring quality compliance and promoting person-centered care within nursing facilities. In November 2024, the Office of Inspector General (OIG) released its Nursing […]
Read More
In November, CMS finalized a change to how RHCs and FQHCs will bill for certain Part B Preventive vaccines as part of the 2025 Medicare Physician Fee Schedule Final Rules. […]
Read More
On January 21, 2025, Indiana Governor Mike Braun signed Executive Order 25-22, addressing the provision of charity care by nonprofit hospitals in the state. The order acknowledges that Indiana does […]
Read More
Updated February 11, 2025 A new recertification window has been announced for the 2025 Grantee recertification period for Consolidated Health Centers, Federally Qualified Health Centers & Look-Alikes, Ryan White Clinics, […]
Read MoreOn November 19, 2024, Senators Charles Grassley and Elizabeth Warren submitted this linked letter to the Internal Revenue Service (IRS) urging the agency to increase its oversight of nonprofit hospitals […]
Read More
We have started to see a number of Medicare Cost Report settlements come through over the past month related to the CMS Ruling 1498-R3. The issue is related to the […]
Read More
Earlier this month, the US District Court for the Northern District of Alabama issued a preliminary approval of the proposed settlement of the class action lawsuit against Blue Cross and […]
Read More
The 340B Drug Pricing Program is more than a pharmacy benefit; it is a lifeline for vulnerable communities and patients. However, as federal scrutiny and manufacturer challenges intensify, maintaining program […]
By Joell Grisel, CPA, Director at Blue & Co. Financial technology keeps evolving at a pace that is hard for many not-for-profits to keep up with. At Blue & Co., […]
In early April 2026, a notice was sent from CMS to each MAC regarding the April 30th, 2026, release of the final FY 2027 wage index data PUFs. May 29th, […]
Copyright © 2026, Blue & Co., LLC.
All Rights Reserved.
